Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma

被引:367
作者
Fan, Qing-Min [1 ,2 ]
Jing, Ying-Ying [1 ]
Yu, Guo-Feng [1 ]
Kou, Xing-Rui [1 ]
Ye, Fei [1 ]
Gao, Lu [1 ]
Li, Rong [1 ]
Zhao, Qiu-Dong [1 ]
Yang, Yang [1 ]
Lu, Zheng-Hua [2 ]
Wei, Li-Xin [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Minimal Invas Therapy Dept 1, Shanghai 200438, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Tumor-associated macrophages; Cancer stem cells; Epithelial to mesenchymal transition; Transforming growth factor-beta1; TGF-BETA; EMT; EXPRESSION; MIGRATION; INVASION; MARKER;
D O I
10.1016/j.canlet.2014.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-associated macrophages (TAMs), a crucial component of immune cells infiltrated in tumor microenvironment, have been found to be associated with progression and metastasis of hepatocellular carcinoma (HCC). In this study, we aimed to clarify the mechanism underlying the crosstalk between TAMs and cancer stem cells (CSCs) in HCC. Mouse macrophage cell line RAW264.7 cells were used to investigate the effects of TAMs on mouse hepatoma cell line Hepa1-6 cells in vivo and vitro. A total of 90 clinical samples had pathology-proven HCC were used to evaluate the distribution of TAMs and CSCs and analyze their value in predicting the prognosis. In the study, we have found that the number of TAMs has a positive correlation with the density of CSCs in the marginal of human HCC. Our results show that, cocultured with TAM-conditioned medium (CM) promoted CSC-like properties in Hepa1-6 cells, which underwent EMT and gained higher invasive capability. TAMs secreted more transforming growth factor-beta1 (TGF-beta1) than other phenotypes of macrophage. Furthermore, depletion of TGF-beta1 blocked acquisition of CSC-like properties by inhibition of TGF-beta1-induced EMT. High expression of CD68 in the EpCAM positive expression HCC tissues was strongly associated with both poor cancer-free survival and overall survival in patients. Our results indicate that the TAMs promote CSC-like properties via TGF-beta1-induced EMT and they may contribute to investigate the prognosis of HCC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 41 条
[1]  
Biswas S.K., 2013, Semin Immunopathol
[2]   Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors [J].
Bonde, Anne-Katrine ;
Tischler, Verena ;
Kumar, Sushil ;
Soltermann, Alex ;
Schwendener, Reto A. .
BMC CANCER, 2012, 12
[3]   Cancer Stem Cell Niche: The Place to Be [J].
Borovski, Tijana ;
Melo, Felipe De Sousa E. ;
Vermeulen, Louis ;
Medema, Jan Paul .
CANCER RESEARCH, 2011, 71 (03) :634-639
[4]   Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease [J].
Boulter, Luke ;
Govaere, Olivier ;
Bird, Tom G. ;
Radulescu, Sorina ;
Ramachandran, Prakash ;
Pellicoro, Antonella ;
Ridgway, Rachel A. ;
Seo, Sang Soo ;
Spee, Bart ;
Van Rooijen, Nico ;
Sansom, Owen J. ;
Iredale, John P. ;
Lowell, Sally ;
Roskams, Tania ;
Forbes, Stuart J. .
NATURE MEDICINE, 2012, 18 (04) :572-579
[5]   EMT and MET in Metastasis: Where Are the Cancer Stem Cells? [J].
Brabletz, Thomas .
CANCER CELL, 2012, 22 (06) :699-701
[6]  
Cook J., 2013, CURR OPIN PHARM
[7]   Tumor Associated Macrophage X Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer [J].
Ding, Jingxian ;
Jin, Wei ;
Chen, Canming ;
Shao, Zhiming ;
Wu, Jiong .
PLOS ONE, 2012, 7 (07)
[8]   TGF-β in progression of liver disease [J].
Dooley, Steven ;
ten Dijke, Peter .
CELL AND TISSUE RESEARCH, 2012, 347 (01) :245-256
[9]   Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells [J].
Ehata, S. ;
Johansson, E. ;
Katayama, R. ;
Koike, S. ;
Watanabe, A. ;
Hoshino, Y. ;
Katsuno, Y. ;
Komuro, A. ;
Koinuma, D. ;
Kano, M. R. ;
Yashiro, M. ;
Hirakawa, K. ;
Aburatani, H. ;
Fujita, N. ;
Miyazono, K. .
ONCOGENE, 2011, 30 (14) :1693-1705
[10]  
European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.jhep.2011.12.001, 10.1016/j.ejca.2011.12.021]